XML 35 R17.htm IDEA: XBRL DOCUMENT v3.3.1.900
Equity-based Compensation
12 Months Ended
Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Equity-based Compensation
EQUITY-BASED COMPENSATION
Stock Awards
Stock awards, which include shares of restricted stock, restricted stock units and restricted performance units, are awarded from time to time to executive officers and certain key employees of the Company. Stock award compensation is recorded based on the award date fair value and charged to expense ratably through the requisite service period. The forfeiture of unvested restricted stock, restricted stock units and restricted performance units causes the reversal of all previous expense recorded as a reduction of current period expense.
A summary of stock award activity is as follows:
 
Years Ended December 31,
 
2015
 
2014
 
2013
 
Stock Awards

Weighted
Average
Award Date
Fair Value
 
Stock Awards
 
Weighted
Average
Award Date
Fair Value
 
Stock Awards
 
Weighted
Average
Award Date
Fair Value
Outstanding, beginning of period
767,540

 
$
21.93

 
555,025

 
$
22.79

 
698,869

 
$
19.39

Restricted shares awarded

 

 
242,722

 
23.76

 
435,025

 
24.09

Restricted stock units awarded
719,305

 
17.32

 
395,352

 
21.75

 
112,401

 
25.11

Restricted shares distributed
(90,607
)
 
19.25

 
(118,828
)
 
23.55

 
(274,784
)
 
19.04

Restricted stock units distributed
(12,646
)
 
19.62

 
(15,277
)
 
21.25

 
(13,761
)
 
18.87

Restricted shares forfeited
(54,045
)
 
23.40

 
(104,013
)
 
23.77

 
(236,388
)
 
23.10

Restricted stock units forfeited
(53,840
)
 
19.14

 
(187,441
)
 
24.48

 
(166,337
)
 
19.55

Outstanding, end of period
1,275,707

 
$
19.60

 
767,540

 
$
21.93

 
555,025

 
$
22.79


Expense associated with stock awards was $6.8 million, $3.0 million, and $4.1 million in 2015, 2014 and 2013, respectively. Unrecognized pre-tax expense of $11.8 million related to stock awards is expected to be recognized over the weighted average remaining service period of 2.0 years for awards outstanding at December 31, 2015.
Deferred Stock Unit Awards
Deferred stock units generally are awarded to directors of the Company and represent the Company’s obligation to transfer one share of the Company’s common stock to the grantee at a future date and generally are fully vested on the date of grant. The expense related to the issuance of deferred stock units is recorded as of the date of the award.
The following table summarizes information about deferred stock unit activity:
 
Years Ended December 31,
 
2015
 
2014
 
2013

Deferred
Stock
Units

Weighted
Average
Award
Date
Fair Value
 
Deferred
Stock
Units
 
Weighted
Average
Award
Date
Fair Value
 
Deferred
Stock
Units
 
Weighted
Average
Award
Date
Fair Value
Outstanding, beginning of period
221,471

 
$
20.10

 
214,455

 
$
19.56

 
181,518

 
$
19.06

Awarded
53,527

 
18.56

 
38,810

 
22.89

 
39,966

 
22.33

Shares distributed
(27,779
)
 
18.76

 
(31,794
)
 
19.70

 
(7,029
)
 
22.67

Outstanding, end of period
247,219


$
19.92

 
221,471

 
$
20.10

 
214,455

 
$
19.56


Expense associated with awards of deferred stock units was $1.0 million, $0.9 million and $0.9 million in 2015, 2014 and 2013, respectively.
Stock Options
Stock options on the Company’s common stock are awarded from time to time to executive officers and certain key employees of the Company. Stock options granted generally have a term of seven to ten years and an exercise price equal to the market value of the underlying common stock on the date of grant.
A summary of stock option activity is as follows:
 
Years Ended December 31,
 
2015
 
2014
 
2013

Shares

Weighted
Average
Exercise
Price
 
Shares
 
Weighted
Average
Exercise
Price
 
Shares
 
Weighted
Average
Exercise
Price
Outstanding at January 1
503,134

 
$
18.18

 
1,208,824

 
$
18.54

 
1,216,809

 
$
18.46

Granted

 

 
38,820

 
24.21

 
29,025

 
25.11

Exercised
(209,205
)
 
13.13

 
(526,359
)
 
16.36

 
(29,511
)
 
20.14

Canceled/Expired
(5,546
)
 
24.21

 
(218,151
)
 
25.61

 
(7,499
)
 
24.58

Outstanding at December 31
288,383


$
21.73

 
503,134

 
$
18.18

 
1,208,824

 
$
18.54

 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at December 31
284,929

 
$
21.78

 
452,236

 
$
18.12

 
933,738

 
$
17.84


In 2015, 2014 and 2013, the Company recorded expense of $0.1 million, $0.6 million and $1.7 million, respectively, related to stock option grants. Unrecognized pre-tax expense related to stock option grants was immaterial at December 31, 2015 and will be fully recognized during 2016.
Financial data for stock option exercises are summarized in the following table (in thousands):

Years Ended December 31,

2015
 
2014
 
2013
Amount collected from stock option exercises
$
2,748

 
$
8,614

 
$
738

Total intrinsic value of stock option exercises
1,108

 
3,771

 
131

Tax benefit of stock option exercises recorded in additional paid-in-capital
209

 
6

 
55

Aggregate intrinsic value of outstanding stock options
173

 
1,231

 
5,383

Aggregate intrinsic value of exercisable stock options
169

 
1,209

 
4,695


The intrinsic value calculations are based on the Company’s closing stock price of $19.31, $18.61 and $21.89 on December 31, 2015, 2014 and 2013, respectively. At December 31, 2015, 1,023,270 and 70,326 shares of common stock were available for equity-based compensation awards pursuant to the 2013 Employee Plan and the 2011 Director Plan, respectively.
The Company uses a binomial option-pricing model for valuation purposes to reflect the features of stock options granted. Volatility, expected term and dividend yield assumptions were based on the Company’s historical experience. The risk-free rate was based on a U.S. treasury note with a maturity similar to the option grant’s expected term. There were no stock options granted during 2015. The fair value of stock options awarded during 2014 and 2013 was estimated at the date of grant based on the assumptions presented in the table below:
 
Years Ended December 31,

2014
 
2013

Range

Weighted Average
 
Range
 
Weighted Average
Grant-date fair value
$11.27

$11.27
 
$12.92
 
$12.92
Volatility
41.6%

41.6%
 
49.8%
 
49.8%
Expected term (years)
7.0

7.0
 
7.0
 
7.0
Dividend yield
—%

—%
 
—%
 
—%
Risk-free rate
2.3%

2.3%
 
1.1%
 
1.1%